Transcriptomic analysis revealed significant increases in cancer hallmark pathways, such as epithelial to mesenchymal transition (EMT), PI3K/AKT/mTOR and transforming growth factor (TGF)β pathway signature scores, in cell lines unresponsive to combination treatments (Extended Data Fig. 1d). Here, MTOR is linked to cancer.